Seagen’s targeted cancer med Tukysa picks up accelerated FDA nod in colorectal cancer esagonowsky Thu, 01/19/2023 – 15:39 More: Seagen's targeted cancer med Tukysa picks up accelerated FDA nod in colorectal cancer Source: fierce
read moreAlnylam, PTC Therapeutics rare disease drugs win backing from England’s NICE zbecker Thu, 01/19/2023 – 11:53 More: Alnylam, PTC Therapeutics rare disease drugs win backing from England's NICE Source: fierce
read moreIs the first NASH drug approval nearing? Intercept stages comeback as FDA sets decision date aliu Thu, 01/19/2023 – 11:06 More: Is the first NASH drug approval nearing? Intercept stages comeback as FDA sets decision date Source: fierce
read moreAmarin, in spat with activist investor, says Sarissa has ‘no plan and no new ideas’ kdunleavy Thu, 01/19/2023 – 10:11 More: Amarin, in spat with activist investor, says Sarissa has 'no plan and no new ideas' Source: fierce
read moreRoche touts industry-first liver cancer win, expects more Tecentriq adjuvant data this year aliu Thu, 01/19/2023 – 09:17 More: Roche touts industry-first liver cancer win, expects more Tecentriq adjuvant data this year Source: fierce
read moreTherapy is among the first to receive a positive draft recommendation under streamlined pilot process More: Amvuttra recommended by NICE for amyloidosis Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals